Authors


Jason Metha

Latest:

Emerging opportunities — and risks — with telehealth in a pandemic

Despite current flexibility, future enforcement could prove to be troublesome


Jason Bacharach, MD

Latest:

Ophthalmologists present data on perfluorohexyloctane eye drops

Researchers share that perfluorohexyloctane eye drops offer rapid relief for dry eye disease, enhancing patient comfort before cataract surgery.


Thomas V. Johnson III, MD, PhD

Latest:

AGS 2025: Achieving success as an academic ophthalmologist with Thomas V. Johnson III, MD, PhD

Clinician-scientists play a vital role in advancing ophthalmology by balancing patient care with research, leveraging clinical insights to drive impactful discoveries, and collaborating across disciplines to stay at the forefront of innovation.


Laxmi Devisetty, MD

Latest:

Envision Summit 2025: Looking forward to upcoming sessions

Laxmi Devisetty, MD, and Eva Kim, MD, look ahead at upcoming sessions focusing on geographic atrophy and refractive and cataract surgery at the Envision Summit 2025.


Antonino Cuttitta, MD

Latest:

Examining stability of aspheric IOL in cataract patients

Bi-sign design compensates for aberrations resulting from misalignment.


Alfonso L. Sabater, MD, PhD

Latest:

Tools can detect corneal nerve damage early

Noncontact esthesiometry screens for all levels of neurotrophic keratitis.


Ira Udell, MD

Latest:

The sky is the limit for allergy pipeline

Growing patient pool is driving clinical trial investment.


Yvonne Ou, MD

Latest:

Lifestyle modifications for glaucoma with Yvonne Ou, MD

Yvonne Ou, MD, a professor of ophthalmology at the University of California San Francisco, spoke about lifestyle modifications for glaucoma at this year's Glaucoma 360 meeting.


Xiaoming Liu, PhD

Latest:

Novel multistage model enhances OCT GA segmentation

Researchers introduce a multistage dual-branch network to improve accuracy and efficiency


Lilia Dumbraveanu, MD, PhD

Latest:

Study examines efficiency of physiotherapy in treating, preventing uncomplicated acquired myopia

Research explores innovative physiotherapeutic approaches to managing myopia progression, showing promising results in slowing its advancement over two years.


Peg Achenbach, OD, FAAO

Latest:

Glaucoma 360: ‘Innovation is marching on’

Adrienne Graves, PhD, and Andrew Iwach, MD, co-founders of Glaucoma 360, highlight the 13th annual Glaucoma 360 New Horizons Forum, held this year at the Westin St. Francis San Francisco on Union Square.


Katrina Ronne

Latest:

Breaking barriers: Australian Society of Ophthalmologists’ first woman CEO steps up

Katrina Ronne shares her vision to empower ophthalmologists, champion equity, and strengthen advocacy for better eye health outcomes across Australia.


John A. Hovanesian, MD

Latest:

Pearls to enhance patient comfort and streamline cataract surgery

Physicians should consider the roles of verbal and ocular anesthesia.


Olivia J. Killeen, MD

Latest:

Anterior segment ischemia following three-muscle strabismus surgery

Case of anterior segment ischemia involves young adult with prior carotid artery injury.


Aaishwariya Gulani

Latest:

Advocacy in Ophthalmology

Discover how advocacy can impact your clinical work and ultimately patient care.


Bria George, PharmD

Latest:

Dropless cataract surgery: Shifting paradigm in postoperative care

Removing drops from procedure increases adherence and comfort for most patients.


Carolyn Majcher, OD, FAAO

Latest:

Unlocking geographic atrophy

Staging AMD accurately and identifying clinical features that are linked with disease progression are key.


S. Barry Eiden, OD, FAAO

Latest:

International Keratoconus Academy continues to provide cutting-edge education

Over the years, IKA has become an invaluable resource for eye care professionals.


Ehsan Sadri, MD, FACS

Latest:

(Part 2) From ophthalmology’s lockdown to lasting change: The pandemic habits that stuck

From revised patient flow to smarter tech adoption, ophthalmologists share which changes from 2020 have become cornerstones of modern care—and how they’re preparing for the next big disruption


Matthew Roe, MD, MHS

Latest:

Big data drives opportunity for real-world evidence

Evidence-based medicine can lead to personalized care, better results for patients


Alex Choi

Latest:

ARVO 2025: Multimodal retinal imaging in asymptomatic APOE ε4 carriers, noncarriers, and Alzheimer Disease

At ARVO 2025, in Salt Lake City, Utah, Alex Choi discussed his poster on APOE carrier genetic status and its relation to Alzheimer disease as well as changes of the retina that might reflect early signs leading to an earlier diagnosis of the disease



Dain B. Brooks, MD

Latest:

Surgical options for normalizing neuroadaptation in patients

Technical details, communication style key to presbyopia-correcting IOL journey.


Alon Kahana, MD, PhD

Latest:

Pearls for the treatment of patients with neurotrophic keratitis

Optimizing corneal neurotization outcomes with cryopreserved amniotic membrane.


Andrew D. Pucker, OD, PhD, FAAO

Latest:

The future of decentralized clinical trials in ophthalmology

Research can drive opportunities for patients with rare diseases


W. Lloyd Clark, MD

Latest:

ACHIEVING IMPROVED OUTCOMES THROUGH PARTNERSHIPS BETWEEN OPTOMETRISTS AND RETINA SPECIALISTS

Considerations in the treatment of diabetic retinopathy and diabetic macular edema.


Fatema Ghasia, MD

Latest:

AI and eye tracking: Technological companions to assess amblyopia in pediatric patients

These tools help fill a gap that current technologies cannot achieve as effectively.


Kenneth A. Beckman, MD, FACS

Latest:

World Cornea Congress IX: Epi-on and accelerated crosslinking with Kenneth Beckman, MD

Epi-on corneal crosslinking is advancing through innovations like supplemental oxygen, chemical oxygenation, and laser-assisted techniques.


Grazia Pertile, MD

Latest:

Retinal detachments: managing retinal folds, role of anterior vitreous

Grazia Pertile, MD, discusses the highlights of her presentations on the management of retinal folds after retinal detachment and the role of the anterior vitreous as a cause of recurrent retinal detachment.


Patipol Tiyajamorn

Latest:

ARVO 2025: Using graph neural networks to differentiate between fast and slow glaucoma progressors

At ARVO 2025, in Salt Lake City, Utah, Patipol Tiyajamorn, talked about his poster on using graph neural networks to identify fast glaucoma progressors solely using optic nerve head morphology at a single time point

© 2025 MJH Life Sciences

All rights reserved.